This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tannock, I. F. Articles by Rauth, A. M. Search for Related Content PubMed PubMed Citation Articles by Tannock, I. F. Articles by Rauth, A. M.

Failure of 2-Deoxy-D-glucose and 5-Thio-D-glucose to Kill Hypoxic Cells of Two Murine Tumors¹

Department of Medicine [I. F. T.] and Division of Physics [I. F. T., P. G., A. M. R.], Ontario Cancer Institute, and Department of Medical Biophysics [I. F. T., A. M. R.], University of Toronto, Toronto, Ontario, Canada M4X 1K9

We have administered the glycolysis inhibitors 2-deoxy-D-glucose and 5-thio-D-glucose to C3H/HeJ mice bearing KHT or 16/C transplantable tumors to seek evidence for hypoxic cell toxicity in vivo. The drugs were given (a) with or without insulin, (b) as large single doses or as multiple hourly injections, and (c) alone or immediately after the tumors had received radiation to kill most of the aerobic cell population. Tumor response was assessed by growth delay or by lung colony assay.

Limiting toxicity of 2-deoxy-D-glucose and 5-thio-D-glucose was neurological, leading to seizures and/or death, and this toxicity was increased by insulin. The drugs had at most minimal effects on the growth of either untreated or irradiated tumors at maximal tolerated doses. Despite the known selective toxicity of these glucose analogues for hypoxic cells in tissue culture, we have found them to be ineffective in killing hypoxic cells of two murine tumors.

¹ Supported by a Research Grant from the National Cancer Institute of Canada and funds from the Ontario Cancer Treatment and Research Foundation.

² To whom requests for reprints should be addressed.

Received 8/ 9/82. Accepted 11/29/82.

This article has been cited by other articles:

				J. L.J. Dearling, U. Qureshi, R. H.J. Begent, and R. B. Pedley Combining Radioimmunotherapy with Antihypoxia Therapy 2-Deoxy-D-Glucose Results in Reduction of Therapeutic Efficacy Clin. Cancer Res., March 15, 2007; 13(6): 1903 - 1910. [Abstract] [Full Text] [PDF]